| Literature DB >> 36183000 |
Anastasia Lisuzzo1, Luca Laghi2, Filippo Fiore3, Kevin Harvatine4, Elisa Mazzotta5, Vanessa Faillace1, Nicoletta Spissu3, Chenglin Zhu6, Livia Moscati7, Enrico Fiore8.
Abstract
Ketosis is one of the most important health problems in dairy sheep. The aim of this study was to evaluate the metabolic alterations in hyperketonemic (HYK) ewes. Forty-six adult Sardinian ewes were enrolled between 7 ± 3 days post-partum. Blood samples were collected from the jugular vein using Venosafe tubes containing clot activator from jugular vein after clinical examination. The concentration of β-hydroxybutyrate (BHB) was determined in serum and used to divide ewes into assign ewes into: Non-HYK (serum BHB < 0.80 mmol/L) and HYK (serum BHB ≥ 0.80 mmol/L) groups. Animal data and biochemical parameters of groups were examined with one-way ANOVA, and metabolite differences were tested using a t-test. A robust principal component analysis model and a heatmap were used to highlight common trends among metabolites. Over-representation analysis was performed to investigate metabolic pathways potentially altered in connection with BHB alterations. The metabolomic analysis identified 54 metabolites with 14 different between groups. These metabolites indicate altered ruminal microbial populations and fermentations; an interruption of the tricarboxylic acid cycle; initial lack of glucogenic substrates; mobilization of body reserves; the potential alteration of electron transport chain; influence on urea synthesis; alteration of nervous system, inflammatory response, and immune cell function.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36183000 PMCID: PMC9526738 DOI: 10.1038/s41598-022-20371-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Mean values ± standard of the mean (SEM) of clinical data and biochemical parameters of dairy ewes divided in group Non-HYK (BHB < 0.80 mmol/L) and group HYK (BHB ≥ 0.80 mmol/L).
| Parameters | Group non-HYK (n = 28) | Group HYK (n = 18) | |
|---|---|---|---|
| Age (years) | 4.60 ± 0.21 | 4.58 ± 0.20 | 0.402 |
| Parity | 3.19 ± 1.47 | 2.33 ± 1.50 | 0.707 |
| BCS1 | 3.13 ± 0.69 | 2.61 ± 1.13 | 0.130 |
| DIM2 | 4.88 ± 0.66 | 4.08 ± 1.22 | 0.815 |
| Daily milk yield (kg/day) | 1.25 ± 0.06 | 1.22 ± 0.04 | 0.827 |
| BHB3 (mmol/L) | 0.63 ± 0.12 | 1.35 ± 0.35 | < 0.001 |
| NEFA4 (mEq/L) | 0.17 ± 0.04 | 0.27 ± 0.05 | 0.146 |
| Glucose (mmol/L) | 4.07 ± 0.14 | 3.43 ± 0.19 | 0.009 |
| Urea (mmol/L) | 6.08 ± 0.33 | 7.66 ± 0.45 | 0.007 |
1Body condition score.
2Days in milk.
3β-Hydroxybutyrate.
4Nonesterified fatty acids.
5P-values corrected with Bonferroni method.
Mean values and standard error of means (SEM) of identified metabolites (μmol/L) within the two groups (group Non-HYK with BHB < 0.80 mmol/L and group HYK with BHB ≥ 0.80 mmol/L).
| Class | Metabolite | Group non-HYK (n = 28) | Group HYK (n = 18) | SEM | |
|---|---|---|---|---|---|
| Amino acids and derivates | Asparagine | 16.00 | 11.80 | 0.76 | < 0.001 |
| Glutamine | 59.20 | 47.50 | 2.00 | < 0.001 | |
| Alanine | 57.40 | 48.90 | 1.78 | 0.001 | |
| Tyrosine | 9.94 | 7.70 | 0.44 | 0.001 | |
| Threonine | 36.70 | 29.80 | 2.02 | 0.013 | |
| 3-Methylhistidine | 10.40 | 13.40 | 0.83 | 0.015 | |
| Histidine | 15.80 | 14.50 | 0.49 | 0.064 | |
| Arginine | 67.00 | 58.50 | 4.99 | 0.076 | |
| Methionine | 4.58 | 4.09 | 0.20 | 0.095 | |
| Glutamate | 61.10 | 55.50 | 2.47 | 0.096 | |
| Valine | 51.00 | 43.70 | 2.61 | 0.097 | |
| Proline | 20.30 | 18.90 | 0.76 | 0.144 | |
| Serine | 24.90 | 23.00 | 1.89 | 0.545 | |
| Aspartate | 1.63 | 1.41 | 0.10 | 0.257 | |
| Lysine | 14.40 | 14.10 | 0.84 | 0.798 | |
| Isoleucine | 25.90 | 25.10 | 1.29 | 0.652 | |
| Leucine | 49.80 | 47.70 | 2.12 | 0.539 | |
| Dimethylglycine | 3.63 | 4.05 | 0.24 | 0.484 | |
| Glycine | 125.00 | 139.00 | 7.79 | 0.283 | |
| Betaine | 20.90 | 20.20 | 1.87 | 0.637 | |
| Phenylalanine | 6.45 | 5.62 | 0.27 | 0.134 | |
| Creatine | 39.10 | 41.60 | 1.87 | 0.631 | |
| Creatinine | 1.16 | 1.14 | 0.10 | 0.744 | |
| Taurine | 24.70 | 21.20 | 2.41 | 0.144 | |
| Sarcosine | 0.57 | 0.54 | 0.02 | 0.369 | |
| N6-Acetyl-Lysine | 6.76 | 6.58 | 0.37 | 0.572 | |
| 2-Aminobutyrate | 6.47 | 6.56 | 0.28 | 0.940 | |
| Organic acids | Succinate | 1.55 | 2.19 | 0.11 | < 0.0001 |
| 3-Hydroxyisobutyrate | 3.60 | 4.52 | 0.25 | 0.009 | |
| Acetate | 134.00 | 170.00 | 11.55 | 0.025 | |
| Formate | 7.59 | 8.41 | 0.52 | 0.395 | |
| Pyruvate | 4.53 | 3.99 | 0.25 | 0.154 | |
| Lactate | 283.00 | 288.00 | 23.40 | 0.905 | |
| Citrate | 22.60 | 26.90 | 2.09 | 0.283 | |
| Fumarate | 0.68 | 0.76 | 0.04 | 0.121 | |
| Alcohols | 2,3-Butanediol | 0.86 | 2.35 | 0.31 | 0.002 |
| Ethanol | 2.12 | 5.56 | 0.94 | 0.008 | |
| Methanol | 15.40 | 48.10 | 11.15 | 0.019 | |
| Glycerol | 18.40 | 19.00 | 2.09 | 0.889 | |
| myo-Inositol | 11.10 | 12.10 | 0.80 | 0.493 | |
| Carbohydrates | Glucose | 1093.00 | 1017.00 | 46.70 | 0.371 |
| Mannose | 7.03 | 8.12 | 0.72 | 0.388 | |
| Lactose | 10.90 | 11.40 | 1.86 | 0.728 | |
| Amine and derivates | TMAO1 | 53.70 | 51.60 | 4.11 | 0.456 |
| Dimethylamine | 0.40 | 0.47 | 0.03 | 0.194 | |
| Fatty acids | Isovalerate | 3.63 | 4.05 | 0.24 | 0.220 |
| Methylsuccinate | 0.57 | 0.78 | 0.12 | 0.358 | |
| Ketone bodies | 3-Hydroxybutyrate | 40.20 | 103.30 | 7.34 | < 0.0001 |
| Acetone | 6.05 | 19.52 | 1.88 | < 0.0001 | |
| Sulfone | Dimethyl sulfone | 10.30 | 10.30 | 0.74 | 0.780 |
| Vitamin | Choline | 2.17 | 2.32 | 0.25 | 0.864 |
| Imidazole | Allantoin | 10.50 | 10.30 | 0.55 | 0.695 |
| Nucleoside | Uridine | 4.05 | 3.81 | 0.19 | 0.492 |
| Guanidine | Methylguanidine | 1.02 | 1.13 | 0.05 | 0.103 |
1Trimethylamine-N-oxide.
2P-values corrected with Bonferroni method.
Figure 1Metabolites changes in group HYP (n = 18; BHB ≥ 0.80 mmol/L) related to tricarboxylic acid cycle (TCA) and urea cycle. Blue rectangles are used to identify amino acids and orange rectangles are used to identify metabolic processes; blue arrows indicate a decrease in metabolite concentration while red arrows indicate an increase in concentration.
Figure 2rPCA model built on the space constituted by the concentration of the molecules which showed a statistically significant difference between different groups. In the scoreplot (A), samples from the two groups are represented with black squares (Group non-HYK; n = 28; BHB < 0.80 mmol/L) and red circles (Group HYK; n = 18; BHB ≥ 0.80 mmol/L). The wide, empty circles represent the median of each samples’ group. The metabolites distribution along the principal component 1 (PC1) is summarized in the boxplot (B). The loading plot (C) reports the significant correlation between the concentration of each substance and its importance over PC 1 (p < 0.05).
Figure 3Dot plot of metabolic pathway influenced by statistically significant metabolites in hyperketonemic ewes or group HYK (n = 18; BHB ≥ 0.80 mmol/L). Color gradient and symbol size represent significant metabolite changes in the corresponding pathway.
Metabolic pathways influenced by significative metabolites in hyperketonemic ewes (Group HYK; n = 18; BHB ≥ 0.80 mmol/L) with their p-value.
| Metabolic pathways | Total1 | Hits2 | Metabolites3 | Holm-Bonferroni corrected | |
|---|---|---|---|---|---|
| Aminoacyl-tRNA biosynthesis | 48 | 5 | Asparagine, glutamine, alanine, threonine and tyrosine | < 0.0001 | 0.003 |
| Alanine, aspartate and glutamate metabolism | 28 | 4 | Asparagine, alanine, glutamine and succinate | < 0.0001 | 0.007 |
| 6 | 1 | Glutamine | 0.001 | 0.095 | |
| Glycolysis/gluconeogenesis | 26 | 2 | Ethanol and acetate | 0.023 | 1.0 |
| Glyoxylate and dicarboxylate metabolism | 32 | 2 | Acetate and glutamine | 0.033 | 1.0 |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 4 | 1 | Tyrosine | 0.036 | 1.0 |
1Total number of metabolites in the pathway based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) database.
2Number of metabolites influenced the pathways in this experiment.
3Metabolites identify by KEGG database.